In an Oct. 16 announcement, HCD said, “This strategic move will significantly enhance HCD’s market presence, expand its geographical footprint, and provide access to a broader customer base while reinforcing relationships with patients, healthcare plans and providers, and manufacturers.”
Gordy Fox, HCD’s founder and CEO, added in the announcement, “The transaction represents a major milestone for HCD by leveraging over 25 years of distinguished expertise in medical supplies. This acquisition aligns with our commitment to delivering personalized and compassionate customer experiences while leveraging Medline’s DMEPOS supplier assets, and continuing to provide our industry expertise and best-in-class customer service.”
Brad Mariam, Medline’s Executive Vice President, said, “With the transition of Medline’s DMEPOS supplier assets to HCD, a company that shares in our commitment to exceptional service and patient care, Medline will continue to focus on its core role as an industry leader in the manufacturing and distribution of quality medical supplies.”
Accelerating a Growth Strategy
Lowell Price, Senior Vice President of Business Development and Chief Growth Officer at HCD, said, “By integrating Medline’s DMEPOS supplier assets, we are accelerating our growth strategy, delivering an avenue for expanded cost efficiencies and member adherence. This strategic move aligns with our commitment to delivering superior customer service, additional product offerings and ensuring reliable delivery to our members. HCD is well-positioned to continue to elevate customer experiences and reinforce our market presence.”
HCD is headquartered in Glen Allen, Va., and is a direct-to-consumer provider of insurance-funded supplies, including diabetes testing, incontinence, urology, ostomy, and wound care supplies.
HCD also provides home medical equipment such as breast pumps, blood pressure monitors, and nutritional supplies. The company was established in 1996.
